Heart transplantation in a child with congenital disorder of glycosylation

Journal of Heart and Lung Transplantation

Volumn 35, Issue 8, 2016, Pages 1048-1049

  Klcovansky, Jakob ^a   Mørkrid, Lars ^b   Möller, Thomas ^a  

^a Department of Pediatric Cardiology ^*  (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; DIURETIC AGENT; MILRINONE;

ANEMIA; BLOOD TRANSFUSION; CARDIOMEGALY; CASE REPORT; CHILD; CONGENITAL DISORDER OF GLYCOSYLATION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY OBSTRUCTION; DOLK GENE; DRUG ELUTING STENT; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; GENE; GENE SEQUENCE; HEART FAILURE; HEART MUSCLE BIOPSY; HEART TAMPONADE; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; LEARNING DISORDER; LETTER; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SCHOOL CHILD; STERNOTOMY; THORAX RADIOGRAPHY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; BIOPSY; CARDIAC MUSCLE; COMPLICATION; FOLLOW UP; GLYCOSYLATION; PATHOLOGY; PROCEDURES;

BIOPSY; CARDIOMYOPATHY, DILATED; CHILD; CONGENITAL DISORDERS OF GLYCOSYLATION; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; GLYCOSYLATION; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; MYOCARDIUM;

EID: 84977562414     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2016.05.007     Document Type: Letter

References (8)

1. 1 National Organization for Rare Disorders. Congenital disorders of glycosylation. 2012. https://rarediseases.org/rare-diseases/congenital-disorders-of-glycosylation/. Accessed November 10, 2015.
2. 2 Jaeken J, van den Heuvel L. Congenital Disorders of Glycosylation. In: Blau N, Duran M, Gibson K M, Dionisi-Vici C (Eds.) Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Springer-Verlag Berlin Heidelberg; 2014:483-512.
3. 3 Jaeken, J., Congenital disorders of glycosylation. Ann NY Acad Sci 1214 (2010), 190–198.
4. 4 Fredriksen, P.M., Ingjer, F., Nystad, W., et al. A comparison of VO2(peak) between patients with congenital heart disease and healthy subjects, all aged 8-17 years. Eur J Appl Physiol Occup Physiol 80 (1999), 409–416.
5. 5 Kranz, C., Jungeblut, C., Denecke, J., et al. Defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. Am J Hum Genet 80 (2007), 433–440.
6. 6 Lefeber, D.J., de Brouwer, A.P.M., Morava, E., et al. Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet, 7, 2011, e1002427.
7. 7 Marquardt, T., Hulskamp, G., Gehrmann, J., et al. Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia. Eur J Pediatr 161 (2002), 524–527.
8. 8 Noelle, V., Knuepfer, M., Pulzer, F., et al. Unusual presentation of congenital disorder of glycosylation type 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedema. Eur J Pediatr 164 (2005), 223–226.